Clinical Trial Update: Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset [NA]

View source ↗

Summary

This clinical trial update describes evaluating intravenous tenecteplase for acute posterior circulation ischemic stroke 4.5–24 hours after onset, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (TNK-tPA) (tenecteplase)

Snippet

Sponsor: The First Affiliated Hospital of University of Science and Technology of China | Conditions: Acute Ischemic Stroke | NA | Status: NOT_YET_RECRUITING